Vivo Opportunity LLC 13D and 13G filings for Viridian Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-13 5:45 pm Purchase | 2022-12-31 | 13G | Viridian Therapeutics, Inc. VRDN | Vivo Opportunity LLC | 1,678,207 4.200% | 378,207 (+29.09%) | Filing |
| 2021-09-30 4:30 pm Purchase | 2021-09-21 | 13G | Viridian Therapeutics, Inc. VRDN | Vivo Opportunity LLC | 1,300,000 7.700% | 1,300,000 (New Position) | Filing |